In line with its expansion strategies, Shanghai based biotechnology and medical-device developer WuXi AppTec Group has a...
In a filing with Shanghai stock exchange, Shanghai pharma said that it has Pharma submitted two non-binding bids to buy ...
The fully integrated plasma based biopharmaceutical company China Biologic has agreed to acquire 80 per cent equity inte...
Beijing recently announced new rules that will speed up approvals of medicines and medical devices, easing bottlenecks i...
Weeks after Chinese pharmaceutical giant Fosun tweaked its acquisition of Hyderabad-based Gland Pharma for $1 billion (R...
A group of Chinese researchers have reported that a Chinese traditional ink could noninvasively and effectively treat ca...
Chinese pharmaceutical firm, Simcere, has inked an exclusive agreement with Amgen to co-develop and commercialize four b...
Shandong Weigao Group Medical Polymer Co. has agreed to buy closely held Argon Medical Devices Inc. for $850 million, co...
Merck, a leading science and technology company, announced the opening of its first BioReliance End-to-End Biodevelopmen...
WuXi NextCODE, a global platform for genomic data, has successfully raised $240 million in Series B financing. The compa...
After the long wait, Chinese firm Fosun pharma has decided to settle with 74 percent stake of India’s Glan...
German industrial group Siemens AG has entered into a partnership with Tsinghua University, one of Siemens' center of kn...
Eight Roads Ventures, the proprietary investment arm of Fidelity International Ltd, has launched its first dedicated Chi...
Magnetic nanoparticle clusters have the power to punch through biofilms to reach bacteria that can foul water treatment ...
Columbia China, a 50-50 joint venture between Seattle’s Columbia Pacific Management and Singapore investment compa...
In a bid to bring operational efficiency and improve data management, Chinese healthcare group Fosun Pharma has ad...
Cambricon, an artificial intelligence (AI) chipmaker based in China, has raised $100 million in series A funding led by ...
Swedish drug giant Medivir recently announced that it has offloaded its exclusive rights to develop, manufacture and com...
